In an updated Drug Safety Communication issued on January 13, 2026, the results did not demonstrate an increased risk of suicidal behavior or ideation, along with other psychiatric adverse events (eg, anxiety, depression, irritability, psychosis), among individuals treated with GLP-1s
In einer iranischen Studie von 2011 gab man 18 untrainierten Mnnern 10 Tage lang tglich 50 mg MSM pro Kilogramm Krpergewicht oder ein Placebo
Rubenstein & Merzenich, 2003) involving either or both upregulated glutamatergic excitatory and down-regulated GABAergic inhibitory systems(Sohal & Rubenstein, 2019)
Standard application scenarios include leveraging glutathione injections to promote liver functions, enhance the bodys defence mechanism, and detoxify